HealthQuill Acquisition
Eli Lily sold its sugar-controlling drug to Amphastar Pharmaceuticals for $1.07 billion.
Drugs Health Pharma

Eli Lilly to sell diabetic nasal drug to Amphastar for $1.07 billion 

Eli Lily sold its sugar-controlling drug to Amphastar Pharmaceuticals for $1.07 billion.

Read More
US-based Merck will buy Prometheus Biosciences for about 10.8 billion to shore up its immunology portfolio to shield itself from eventual revenue loss as patents on its cancer immunotherapy Keytruda expires by the end of the decade.
Drugs Pharma

Merck to acquire Prometheus for $10.8 billion to step up immunology presence

HQ Team April 17, 2023: US-based Merck will buy Prometheus Biosciences for about 10.8 billion to shore up its immunology portfolio to shield itself from.

Read More
Dr. Reddy’s Laboratories, an Indian maker of generics and active pharmaceutical ingredients, has completed the acquisition of Mayne Pharma’s U.S. generic prescription portfolio.
Drugs Health Medical Pharma

Dr. Reddy’s completes Mayne Pharma’s U.S. portfolio buyout

H.Q. Team April 7, 2023: Dr. Reddy’s Laboratories, an Indian maker of generics and active pharmaceutical ingredients, has completed the acquisition of Mayne.

Read More
Pfizer will acquire Seagen for $43 billion to beef up its cancer portfolio, with COVID-19 vaccine sales forecast to plummet.
Drugs Medical Pharma

Pfizer to buy Seagen for $43 billion to fortify cancer portfolio

Pfizer will acquire Seagen for $43 billion to beef up its cancer portfolio, with COVID-19 vaccine sales forecast to plummet.

Read More
Globus Medical, a US-based publicly traded medical device company making products to treat musculoskeletal disorders, acquired NuVasive in an all-stock deal worth $3.1 billion
Drugs Medical Pharma

Globus Medical buys NuVasive in all-stock for $3.1 billion

Globus Medical, a US-based publicly traded medical device company making products to treat musculoskeletal disorders, acquired NuVasive in an all-stock deal worth $3.1.

Read More
Amgen acquisition
Drugs Pharma

Amgen to buy Dublin-based Horizon for $27.8 billion

Amgen Inc, one of the world's largest biotechnology companies, will acquire Dublin-based Horizon Therapeutics Plc for $27.8 billion.

Read More
Merck acquisition
Drugs Pharma

Merck acquires Imago BioSciences for $1.35 billion

Merck, a US multinational pharmaceutical company, announced it would acquire Imago BioSciences for $1.35 billion.

Read More
Viatris acquisition
Drugs Health Pharma

Viatris acquires two companies for $750 million to sharpen ophthalmology vision

Viatris acquires two companies for $750 million to fuel ophthalmology vision

Read More
hypertension
Medical

Hetero buys J&J’s manufacturing site in India

HQ Team October 18, 2022: Hetero, an Indian pharmaceutical company, announced the acquisition of a brownfield manufacturing plant of Johnson & Johnson Private.

Read More
Acquisition
Drugs Pharma

Torrent acquires Curatio healthcare for $305 million

HQ team Torrent Pharmaceuticals Limited announced it would buy Indian company Curatio Healthcare (I) Private Limited, for INR 2,500 crore ($305 million), according.

Read More